Shannon Risacher, PhD Linkedin Twitter Google My main research interest is in identifying biomarkers for early detection of Alzheimer’s disease pathology before clinical symptoms. Although I primarily evaluate neuroimaging measures from magnetic resonance imaging (MRI) and positron emission tomography (PET) techniques, I have significant interest in developing novel biomarkers. I am particularly interested in visual, […]
Shane Liddelow, PhD Linkedin Twitter Google Shane gained his Bachelors of Science (Hons) and Biomedical Science from the University of Melbourne, Australia, majoring in Neuroscience and Anatomy & Cell Biology. He received his PhD with Katarzyna Dziegielewska and Norman Saunders in Pharmacology also from the University of Melbourne. His graduate work focused on the protective
Eloise Hudry, PhD Linkedin Google Eloise Hudry, PhD, is Assistant Professor of Neurology at Harvard Medical School and have been working at the MassGeneral Institute of Neurodegenerative Diseases (MIND) since 2009. She is currently a group leader for a small team of 5 people. MIND was founded with the mission to translate laboratory discoveries into finding new
Kristen Funk, PhD Linkedin Twitter Google The contribution of the immune system to homeostatic brain function is a growing field that is still not well understood; however, neuroinflammation is increasingly associated with neurocognitive disorders including Alzheimer’s disease (AD) and post-infectious West Nile virus (WNV) encephalitis, illustrating a need for better understanding of these interactions. My
Gregory (Gregg) S. Day, M.D Twitter Google I maintain special clinical interest in the diagnosis and management of patients with rapidly progressive dementia (including Creutzfeldt-Jakob disease), and autoimmune-mediated encephalitis (including patients with NMDA-receptor encephalitis and similar diseases). My research strives to integrate clinical (e.g., symptoms and signs) and paraclinical measures (e.g., structural/functional/PET neuroimaging, cerebrospinal fluid biomarkers)
Rachel Buckley, PhD Linkedin Twitter Google Rachel is a lead investigator of the Healthy Brain Project and an early career research fellow at Harvard Medical School and The Florey Institute of Neuroscience and Mental Health. Her research interests focus on early detection of dementia via subjective concerns of memory decline and determining the reliability of
Anthony Filiano, PhD Linkedin Twitter Google Immune dysfunction has been described in most neurological disorders. Preclinical strategies targeting these disorders have primarily concentrated on directly targeting synaptic function; however, most of these approaches have failed. Our lab is interested in understanding the complex interactions between the immune system and nervous system with the intent to
Veronique Belzil, PhD Linkedin Google Dr. Belzil is an Associate Professor of Neurology at Vanderbilt University Medical Center where she also serves as the Director of the Vanderbilt ALS Research Center. She obtained her bachelor’s degree in psychology from McGill University in 2003 and her master’s degree in psychology from Walden University in 2007. Continuing
